Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1968 1
1969 1
1970 3
1972 2
1973 1
1974 3
1976 1
1977 2
1978 1
1979 1
1980 5
1981 5
1982 5
1983 5
1984 3
1985 5
1986 9
1987 10
1988 9
1989 12
1990 12
1991 15
1992 17
1993 17
1994 12
1995 8
1996 19
1997 9
1998 11
1999 9
2000 10
2001 9
2002 5
2003 5
2004 5
2005 2
2006 3
2007 3
2008 4
2010 2
2011 3
2012 3
2013 5
2014 3
2015 3
2016 1
2017 5
2018 3
2019 2
2022 2
2023 2
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

298 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Interventions for the prevention of recurrent erysipelas and cellulitis.
Dalal A, Eskin-Schwartz M, Mimouni D, Ray S, Days W, Hodak E, Leibovici L, Paul M. Dalal A, et al. Cochrane Database Syst Rev. 2017 Jun 20;6(6):CD009758. doi: 10.1002/14651858.CD009758.pub2. Cochrane Database Syst Rev. 2017. PMID: 28631307 Free PMC article. Review.
Systemic antibiotics for symptomatic apical periodontitis and acute apical abscess in adults.
Cope AL, Francis N, Wood F, Chestnutt IG. Cope AL, et al. Cochrane Database Syst Rev. 2018 Sep 27;9(9):CD010136. doi: 10.1002/14651858.CD010136.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2024 May 7;5:CD010136. doi: 10.1002/14651858.CD010136.pub4 PMID: 30259968 Free PMC article. Updated. Review.
Both trials were conducted in university dental schools in the USA and compared the effects of oral penicillin V potassium (penicillin VK) versus a matched placebo when provided in conjunction with a surgical intervention (total or partial pulpectomy) and analgesics …
Both trials were conducted in university dental schools in the USA and compared the effects of oral penicillin V potassium (pe …
Pharmacokinetics of phenoxymethylpenicillin in tonsils.
Roos K, Grahn E, Ekedahl C, Holm SE. Roos K, et al. Scand J Infect Dis. 1986;18(2):125-30. doi: 10.3109/00365548609032318. Scand J Infect Dis. 1986. PMID: 3085212 Clinical Trial.
The pharmacokinetics of phenoxymethylpenicillin in tonsillar tissue was studied in 33 patients who underwent tonsillectomy, mainly because of repeated tonsillitis or peritonsillitis. ...
The pharmacokinetics of phenoxymethylpenicillin in tonsillar tissue was studied in 33 patients who underwent tonsillectomy, mainly be …
Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: randomised controlled, open label, non-inferiority study.
Skoog Ståhlgren G, Tyrstrup M, Edlund C, Giske CG, Mölstad S, Norman C, Rystedt K, Sundvall PD, Hedin K. Skoog Ståhlgren G, et al. BMJ. 2019 Oct 4;367:l5337. doi: 10.1136/bmj.l5337. BMJ. 2019. PMID: 31585944 Free PMC article. Clinical Trial.
OBJECTIVE: To determine whether total exposure to penicillin V can be reduced while maintaining adequate clinical efficacy when treating pharyngotonsillitis caused by group A streptococci. ...Adverse events were mainly diarrhoea, nausea, and vulvovaginal disorders; …
OBJECTIVE: To determine whether total exposure to penicillin V can be reduced while maintaining adequate clinical efficacy whe …
Efficacy of high doses of penicillin versus amoxicillin in the treatment of uncomplicated community acquired pneumonia in adults. A non-inferiority controlled clinical trial.
Llor C, Pérez A, Carandell E, García-Sangenís A, Rezola J, Llorente M, Gestoso S, Bobé F, Román-Rodríguez M, Cots JM, Hernández S, Cortés J, Miravitlles M, Morros R. Llor C, et al. Aten Primaria. 2019 Jan;51(1):32-39. doi: 10.1016/j.aprim.2017.08.003. Epub 2017 Oct 20. Aten Primaria. 2019. PMID: 29061311 Free PMC article. Clinical Trial.
OBJECTIVES: To evaluate whether high-dose penicillin V is as effective as high-dose amoxicillin for the treatment of non-severe CAP. ...PARTICIPANTS: Patients from 18 to 75 years of age with no significant associated comorbidity and with symptoms of lower respirator …
OBJECTIVES: To evaluate whether high-dose penicillin V is as effective as high-dose amoxicillin for the treatment of non-sever …
Phenoxymethylpenicillin two or three times daily in bacterial upper respiratory tract infections: a blinded, randomized and controlled clinical study.
Fyllingen G, Arnesen AR, Rønnevig J. Fyllingen G, et al. Scand J Infect Dis. 1991;23(6):755-61. doi: 10.3109/00365549109024304. Scand J Infect Dis. 1991. PMID: 1815339 Clinical Trial.
In relation to compliance problems it was investigated whether phenoxymethylpenicillin dosed 2 or 3 times daily was equally effective in bacterial upper respiratory infections. ...There was no statistically significant difference. In conclusion phenoxymethylpenicillin …
In relation to compliance problems it was investigated whether phenoxymethylpenicillin dosed 2 or 3 times daily was equally effective …
Phenoxymethylpenicillin two or three times daily for tonsillitis with beta-haemolytic streptococci group A: a blinded, randomized and controlled clinical study.
Fyllingen G, Arnesen AR, Biermann C, Kaarby O, Romfo O, Rønnevig J, Aaserud J. Fyllingen G, et al. Scand J Infect Dis. 1991;23(5):553-8. doi: 10.3109/00365549109105177. Scand J Infect Dis. 1991. PMID: 1767251 Clinical Trial.
In relation to compliance problems it was investigated whether phenoxymethylpenicillin dosed twice or 3 times daily was equally effective in tonsillitis due to beta-haemolytic streptococci group A. ...The difference was not statistically significant. In conclusion, phen …
In relation to compliance problems it was investigated whether phenoxymethylpenicillin dosed twice or 3 times daily was equally effec …
Towards pharmacokinetic boosting of phenoxymethylpenicillin (penicillin-V) using probenecid for the treatment of bacterial infections.
Wilson RC, Riezk A, Arkell P, Ming D, Armiger R, Latham V, Gilchrist MJ, Märtson AG, Hope WW, Holmes AH, Rawson TM. Wilson RC, et al. Sci Rep. 2024 Jul 21;14(1):16762. doi: 10.1038/s41598-024-67354-6. Sci Rep. 2024. PMID: 39034340 Free PMC article. Clinical Trial.
Twenty participants took six doses of penicillin-V (250 mg, 500 mg or 750 mg four times daily) with and without probenecid. Total and free concentrations of penicillin-V and probenecid were measured at two timepoints. ...The mean difference (95% CI) be …
Twenty participants took six doses of penicillin-V (250 mg, 500 mg or 750 mg four times daily) with and without probenecid. To …
Loracarbef versus phenoxymethylpenicillin in the treatment of recurrent streptococcal pharyngotonsillitis.
Roos K, Larsson P. Roos K, et al. Scand J Infect Dis. 1997;29(2):141-5. doi: 10.3109/00365549709035874. Scand J Infect Dis. 1997. PMID: 9181649 Clinical Trial.
This multicentre, double-blind, randomized trial was designed to compare the efficacy of loracarbef (200 mg twice daily) vs phenoxymethylpenicillin (penicillin V) (800/1000 mg twice daily) each for 10 days in the treatment of recurrent group A streptococcal p …
This multicentre, double-blind, randomized trial was designed to compare the efficacy of loracarbef (200 mg twice daily) vs phenoxymethyl …
Systemic antibiotics in the surgical treatment of peri-implantitis: A randomized placebo-controlled trial.
Riben Grundström C, Lund B, Kämpe J, Belibasakis GN, Hultin M. Riben Grundström C, et al. J Clin Periodontol. 2024 Aug;51(8):981-996. doi: 10.1111/jcpe.13994. Epub 2024 May 3. J Clin Periodontol. 2024. PMID: 38699828 Clinical Trial.
MATERIALS AND METHODS: Eighty-four patients (113 implants) with peri-implantitis were randomized into three groups (A, amoxicillin and metronidazole; B, phenoxymethylpenicillin and metronidazole; or C, placebo). Treatment included resective surgery and implant surface deco …
MATERIALS AND METHODS: Eighty-four patients (113 implants) with peri-implantitis were randomized into three groups (A, amoxicillin and metro …
298 results

Searches related to "phenoxymethylpenicillin"